COVID-19: Role of superinfections in novel coronavirus deaths highlights urgent need for sustainable development of new antibiotics

By on .

Dr. Neil J. Clancy

The following is a guest post by Cornelius (Neil) J. Clancy, M.D.

To date, there are limited data on superinfections associated with COVID-19, the pandemic disease caused by the novel coronavirus SAR-CoV-2. A handful of published reports, however, largely from China, suggest that bacterial and fungal superinfections may occur in a significant percentage of patients with severe COVID-19, and that these infections are caused at least in some hospitals by antimicrobial-resistant, nosocomial pathogens. Early experience indicates that almost with all patients with severe COVID-19 receive broad spectrum antimicrobials, either for treatment of a diagnosed superinfection, or empirically due to the possibility of such an infection. An association between COVID-19 and superinfections is plausibly driven by two, non-exclusive explanations. First, SARS-CoV-2 infection leads to immune system dysregulation in severe infections, which may leave patients vulnerable to bacterial or fungal proliferation[i]. Second, critically ill patients, especially those in intensive care units or receiving mechanical ventilation, are at markedly increased risk for bacterial and fungal infections, independent of COVID-19.

Superinfections were reported in 10%-20% of SARS-CoV-2-infected adults admitted to Wuhan, China hospitals through the end of January 2020, including 50%-100% of those who died[ii]. Superinfections were diagnosed in 31% of ICU patients with COVID-19 at one of these hospitals[iii]. Types of infections were bacterial or fungal pneumonia (9% of ICU patients), pneumonia with bacteremia (2%), and bacterial urinary tract infection (2%)[iv]. Organisms cultured from patients were typically highly resistant to antimicrobials, and each is found in the 2019 Centers for Disease Control’s Report on Antibiotic Resistance Threats 2019, including Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae, extended spectrum beta lactamase (ESBL)-producing K. pneumoniae and Pseudomonas aeruginosa Aspergillus fumigatus, Aspergillus flavus and Candida albicans. Infections were typically diagnosed more than two weeks after the onset of COVID-19 symptoms, and they often occurred only days prior to death[v]. Bacterial and fungal infections, then, in particular those caused by antimicrobial-resistant pathogens, appear to have been significant causes of death among COVID-19 patients in Wuhan hospitals. In the first European COVID-19 case series, one of three patients with severe disease in France died after being diagnosed with secondary Acinetobacter baumannii and A. flavus co-infection[vi].

In studies from Chinese hospitals, 80%-100% and 7.5% of patients with severe COVID-19 were treated with antibiotics and antifungal agents, respectively[vii]. Broad-spectrum antibiotics including carbapenems, cephalosporins, fluoroquinolones and linezolid were prescribed most commonly[viii]. Antimicrobial agents were typically used empirically, rather than against diagnosed infections, because 25%-75% of severely ill COVID-19 patients show evidence of sepsis, and it is very difficult to exclude bacterial or fungal superinfections based on signs and symptoms, physical findings, radiographic abnormalities and laboratory results. The French patient with severe COVID-19 and apsergillosis was treated with various combinations of meropenem, tigecycline, levofloxacin, aerosolized colistimethate, voriconazole and/or isavuconazole before dying of multisystem organ failure on the 24th day after onset of COVID-19 symptoms[ix].

Anecdotal reports of bacterial and fungal infections complicating COVID-19 similar to those from China and France are appearing on social media from physicians in New York, California, Washington, the Netherlands, the United Kingdom and other locales seeing high volumes of cases. It is likely, then, that we will need a steady supply of broad-spectrum antibiotics to treat severely ill COVID-19 patients, particularly in ICUs. In many instances, newly U.S. Food and Drug Administration-approved antibiotics of last resort against carbapenem resistant Enterobacteriaceae and other highly resistant pathogens will be needed. Tellingly, several companies responsible for bringing these new drugs through FDA approval have declared bankruptcy or left the antimicrobial field due to insufficient economic return in the marketplace. The COVID-19 crisis will vividly highlight why reimbursement models for antibiotics must be delinked from per unit use of these drugs, but rather more fairly reflect their societal and public health value. Second, the widespread use of broad-spectrum antibiotics in patients with severe COVID-19 may promote the emergence of further antibiotic resistance in U.S. hospitals. We need to assure that the economic model for antibiotics promotes the sustainable development of new drugs.

Neil J. Clancy, M.D. is an infectious diseases physician and researcher.  He is tenured Associate Professor of Medicine, Director of the XDR Pathogen Lab, and Associate Chief of Infectious Diseases at the University of Pittsburgh, and Chief of Infectious Diseases at the VA Pittsburgh Healthcare System.  He conducts collaborative clinical, translational and laboratory research on issues relevant to the treatment, diagnosis and prevention of infections in immunosuppressed and other vulnerable patient populations, including those caused by antimicrobial-resistant pathogens. He is a member of the Infectious Diseases Society of America (which produces this blog), a member of IDSA’s Antimicrobial Resistance Committee, and serves on clinical and laboratory guideline committees for  IDSA (Candida guidelines and Antimicrobial resistant infection treatment guidance).

[i] Chen, Journal of Clinical Investigation; Huang, The Lancet

[ii] Zhou F, The Lancet; Cao, Clinical Infectious Diseases; Huang

[iii] Huang

[iv] Yang, Lancet Respiratory Medicine

[v] Zhou

[vi] Lescure, Lancet Infectious Diseases

[vii] Tao Chen, BMJ; Guan, New England Journal of Medicine; Huang

[viii] Tao Chen; Cao

[ix] Lescure

72 thoughts on “COVID-19: Role of superinfections in novel coronavirus deaths highlights urgent need for sustainable development of new antibiotics

  1. Pingback: COVID-19: will secondary bacterial infections become a major cause of death? - Antibiotic Research UK

  2. Afaf El-Ansary

    Thanks for such a very interesting topic highlighting the global problem of antibiotic resistance as etiological mechanism of increased COVID-19 deaths

    Reply
  3. Pingback: Covid-19 May Worsen the Antibiotic Resistance Crisis | WIRED

  4. Pingback: Covid-19 May Worsen the Antibiotic Resistance Crisis – Altec

  5. Pingback: Covid-19 May Worsen the Antibiotic Resistance Crisis | Benrox Holdings, LLC

  6. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic | Skugal

  7. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – Anastasios Pallis

  8. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic | 1 Business

  9. Pingback: Overuse of Antibiotics In the Pandemic Could Undermine Lifesaving Drugs - COVID-19 World News

  10. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – Politicopathy

  11. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic

  12. Pingback: Coronavirus Live Updates: Overuse of Antibiotics In the Pandemic Could Undermine Lifesaving Drugs - Newscontest

  13. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – USA All Americans NEWS™

  14. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - Saubio Success

  15. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - OPERNAL

  16. Pingback: Coronavirus Live Updates: Overuse of Antibiotics In the Pandemic Could Undermine Lifesaving Drugs - Sound Health and Lasting Wealth

  17. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – JB News Network

  18. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - Latest breaking news | NZ | world | dailyexpress.co.nz

  19. Pingback: Coronavirus Live Updates: Overuse of Antibiotics In the Pandemic Could Undermine Lifesaving Drugs – Get Fit Winnipeg

  20. Pingback: Live Coronavirus News Updates | Skugal

  21. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - Social Distance Plan

  22. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – My blog

  23. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – The New York Times – JB News Network

  24. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – The New York Times – Health 4 Everyday

  25. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - Hot 5 News

  26. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – Pinocolada

  27. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – The New York Times | yeoys.com

  28. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – Go High Radio USA

  29. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic | Weight and Fitness

  30. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – Mentor News

  31. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - mattorie.com

  32. Pingback: Coronavirus Global News Tracker: Live Updates – Bistosh World

  33. Pingback: Coronavirus Live Updates: Overuse of Antibiotics in the Pandemic Could Undermine Lifesaving Drugs – Alpha News Today

  34. Pingback: Coronavirus Worldwide Info Tracker: Dwell Updates – Today Topic

  35. Pingback: Coronavirus Live Updates: two major Covid-19 studies are withdrawn - My Hot News Pakistan

  36. Pingback: Coronavirus Live Updates: Two Major Covid-19 Studies Are Retracted - Sound Health and Lasting Wealth

  37. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - News | New York AM

  38. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic | FEELS LIKE <b>ARMA.GDN</b>

  39. Pingback: Coronavirus Live Updates: Two Major Covid-19 Studies Are Retracted – Get Fit Winnipeg

  40. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - Latest Breaking News for US and the World

  41. Pingback: Coronavirus Global News Tracker: Live Updates – Troomo

  42. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – Troomo

  43. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – The New York Times | KEKE NEWS ONLLINE

  44. Pingback: Doctors Carefully Overprescribed Antibiotics Early within the Pandemic - News Himalaya

  45. Pingback: Coronavirus Live Updates: Surging Caseloads Put Strongmen on the Back Foot - Sound Health and Lasting Wealth

  46. Pingback: Coronavirus Global News Tracker: Live Updates – WorldNewsDelivered.

  47. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – WorldNewsDelivered.

  48. Pingback: Coronavirus Live Updates: Surging Caseloads Put Strongmen on the Back Foot – Get Fit Winnipeg

  49. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot – USA All Americans NEWS™

  50. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot - Social Distance Plan

  51. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot – Serialpressit (News) - Thenew Mag

  52. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot – Politicopathy

  53. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot | Skugal

  54. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot – Pinocolada

  55. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot | NewsColony

  56. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot – Get Fit Winnipeg

  57. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot - FAQS Coronavirus COVID-19

  58. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot | Small Business Minder

  59. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot - Times Famous

  60. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - The New York Times - AllNewsFeed

  61. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot » What's Goon

  62. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - The New York Times - Health n News

  63. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - The New York Times - SleepingRex

  64. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - anisanews.com

  65. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - The New York Times - Health News

  66. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - Cameleon News

  67. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - smartproductdeluxe.com

  68. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – TDimage Life

  69. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot – Alpha News Today

  70. Pingback: Surging Coronavirus Caseloads Put Strongmen on the Back Foot - Latest breaking news | NZ | world | dailyexpress.co.nz

  71. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic – The Info

  72. Pingback: Doctors Heavily Overprescribed Antibiotics Early in the Pandemic | World News

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.